secwatch.observer — SEC 8-K summary
======================================

Issuer:     Picard Medical, Inc. (PMI)
CIK:        0002030617
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001829126-25-009146
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Picard Medical Q3 revenue up 35% to $1.19M; IPO nets $15.5M in September
------------------------------------------------------------------------

- Revenue $1.19M (+35% YoY); gross loss narrowed 81% to $0.13M; operating loss $3.36M vs $3.77M.
- Net loss $22.7M includes $12.4M non-cash derivative revaluation charge upon IPO debt conversion.
- IPO completed Sept 2: $19.5M gross proceeds ($15.5M net); retired convertible debt.
- Appointed independent directors Sam Van and George Ye; patent granted for next-gen Emperor artificial heart.
- Year-to-date revenue $3.93M (+11%); operating loss $10.3M; EPS ($0.96) vs ($1.79) prior.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030617/000182912625009146/0001829126-25-009146-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030617/000182912625009146/picardmedical_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-009146

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer